Pharmaceuticals

Drug Development Drug Pricing Drug Safety Drug Approval Weight Loss Drugs Clinical Trials Prescription Drugs Drug Manufacturing Drug Regulation Prescription Medications

Doctors Warn of Unregulated Peptide Injection Boom Fueled by Social Media

Experts warn the vogue for anti-ageing injections relies on unapproved products with unproven benefits.

Barclays Lifts Hims & Hers Target After Novo Drops Suit and GLP‑1 Deal

MHRA Approves Leqselvi for Severe Alopecia Areata in Adults

Stories older than 24h

Hims & Hers Soars as Novo Nordisk Reinstates Supply Deal for Ozempic and Wegovy

NICE Recommends Fezolinetant for NHS Use in England to Treat Menopausal Hot Flushes and Night Sweats

Watchdog Says Minors Can Buy Cross-Sex Hormones Online With 'Alarming Ease'

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

New Adult Stimulant Prescriptions in Ontario More Than Doubled After 2020, CMAJ Study Finds

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

Indian National Sentenced to 43 Months for Counterfeit Keytruda Scheme

Eli Lilly Unveils Employer Connect, Offering Zepbound to Employers at a Uniform $449 Net Price

FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded GLP-1 Drugs

Can-Fite's Namodenoson Clears Phase IIa Safety Bar in Pancreatic Cancer

FDA Clears First Generic Flovent HFA Inhaler as Glenmark Prepares U.S. Launch

FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded GLP-1 Weight-Loss Drugs

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Xeris Biopharma Sets 2026 Revenue Outlook at $375–$390 Million, Targets H2 Start for XP-8121 Phase III

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

FDA Maps New Paths for Rare-Disease Drug Evidence, Keeps Bar High